Research programme: cell-permeable RNAi prodrugs - Solstice Biologics
Alternative Names: RiboNucleic NeutralsLatest Information Update: 16 Jul 2016
At a glance
- Originator University of California, San Diego
- Developer Solstice Biologics; University of California, San Diego
- Class Small molecules
- Mechanism of Action Protein inhibitors; RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Undefined in USA
- 04 Jan 2013 Early research in Undefined indication in USA (unspecified route)